Stocks News

LAST PRICE
252.3800
TODAY'S CHANGE (%)
Trending Up3.8400 (1.5450%)

Bid / Lots
246.4100/ 1
Ask / Lots
261.9800/ 1
Open / Previous Close
249.0000 / 248.5400
Day Range
Low 248.5250
High 255.1600
52 Week Range
Low 140.8100
High 260.4900
Volume
930,321
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 6, 2024
- DJ U.S. Tariffs Could Force Moves by Australian Med-Techs -- Market Talk, from 10:53PM ET on Wednesday Nov 06, 2024 by Dow Jones
  10:53PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: RMD
  
  0353 GMT - Australia-listed drug and device makers may have to consider moving production due to potential tariffs by the incoming Trump administration, UBS analysts write in a note. They say that the likes of vaccine giant CSL, hearing-implant maker Cochlear, breath-tech provider ResMed and radiopharmaceutical developer Telix may have to consider the origin of various inputs and the location of production. Tariffs could motivate relocation of facilities to the U.S. but result in lower profitability for companies, they say. Protective-garment maker Ansell could benefit from tariffs on Chinese gloves, they add. (stuart.condie@wsj.com)
Nov 5, 2024
- ResMed Announces Participation in the UBS Global Healthcare Conference, from 4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
  4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: RMD
  
  ResMed Announces Participation in the UBS Global Healthcare Conference
  
  SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will participate in a fireside chat at the UBS Global Healthcare Conference on Tuesday, November 12, 2024, beginning at approximately 3:30 p.m. (Pacific Standard Time) at the Terranea Resort Hotel in Rancho Palos Verdes, CA.
Oct 29, 2024
- SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of ResMed Inc. (NYSE:RMD) and Encourages Investors to Contact the Firm, from 8:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
  8:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
  Companies Mentioned: RMD
  
  SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of ResMed Inc. (NYSE:RMD) and Encourages Investors to Contact the Firm
  
  PHILADELPHIA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating ResMed Inc. (NYSE:RMD) on behalf of the company's shareholders.
Oct 27, 2024
- DJ ResMed's External Drivers Look Strong to Bull -- Market Talk, from 8:19PM ET on Sunday Oct 27, 2024 by Dow Jones
  8:19PM ET on Sunday Oct 27, 2024 by Dow Jones
  Companies Mentioned: RMD
  
  0019 GMT - ResMed's bulls at Wilsons say external demand drivers are the most powerful they've seen in 16 years covering the breathing-tech provider. The broker's analysts point to the positive impact of rising health awareness from smart devices, plus obesity treatment and awareness. ResMed's market dominance and tech capabilities also support their continued overweight recommendation. With the stock rallying to trade at 20X Ebitda, they call recent worries over the potential impact of weight-loss drugs "nonsense". Wilsons lifts the stock's target price 4.8% to A$42.18. Shares are up 1.5% at A$38.29.(stuart.condie@wsj.com)
- *DJ ResMed Price Target Raised 15% to A$41.33/Share by Morgans, from 6:53PM ET on Sunday Oct 27, 2024 by Dow Jones
  6:53PM ET on Sunday Oct 27, 2024 by Dow Jones
  Companies Mentioned: RMD

Yesterday
- Edwards Lifesciences Corporation Class Action: Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW, from 9 hours ago by Dow Jones
  9 hours ago by Dow Jones
  Companies Mentioned: EW
- ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - EW, from 9 hours ago by Newsfile
  9 hours ago by Newsfile
  Companies Mentioned: EW
- ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - EW, from 9 hours ago by Dow Jones
  9 hours ago by Dow Jones
  Companies Mentioned: EW
- Investors who lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW, from 10 hours ago by Dow Jones
  10 hours ago by Dow Jones
  Companies Mentioned: EW
- DJ Veeva Systems Is Maintained at Overweight by Barclays, from 12 hours ago by Dow Jones
  12 hours ago by Dow Jones
  Companies Mentioned: VEEV
- DJ Veeva Systems Is Maintained at Outperform by RBC Capital, from 13 hours ago by Dow Jones
  13 hours ago by Dow Jones
  Companies Mentioned: VEEV
- Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW, from 13 hours ago by Dow Jones
  13 hours ago by Dow Jones
  Companies Mentioned: EW
- DEADLINE ALERT for IREN, AILE, and EW: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders, from 14 hours ago by Dow Jones
  14 hours ago by Dow Jones
  Companies Mentioned: EW, AILE, IREN
- Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW, from 14 hours ago by Dow Jones
  14 hours ago by Dow Jones
  Companies Mentioned: EW
- UBS Adjusts Price Target on Veeva Systems to $245 From $215, Maintains Neutral Rating, from 14 hours ago by MT Newswires
  14 hours ago by MT Newswires
  Companies Mentioned: VEEV

Resmed Inc
NYSE:RMDUnited States

Search Criteria

Nov 6, 2024

DJ U.S. Tariffs Could Force Moves by Australian Med-Techs -- Market Talk, from 10:53PM ET on Wednesday Nov 06, 2024 by Dow Jones

Nov 5, 2024

ResMed Announces Participation in the UBS Global Healthcare Conference, from 4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones

Oct 29, 2024

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of ResMed Inc. (NYSE:RMD) and Encourages Investors to Contact the Firm, from 8:30AM ET on Tuesday Oct 29, 2024 by Dow Jones

Oct 27, 2024

DJ ResMed's External Drivers Look Strong to Bull -- Market Talk, from 8:19PM ET on Sunday Oct 27, 2024 by Dow Jones

*DJ ResMed Price Target Raised 15% to A$41.33/Share by Morgans, from 6:53PM ET on Sunday Oct 27, 2024 by Dow Jones

Peers Headlines

Yesterday

Edwards Lifesciences Corporation Class Action: Levi & Korsinsky Reminds Edwards Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW, from 9 hours ago by Dow Jones

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - EW, from 9 hours ago by Newsfile

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - EW, from 9 hours ago by Dow Jones

Investors who lost money on Edwards Lifesciences Corporation(EW) should contact Levi & Korsinsky about pending Class Action - EW, from 10 hours ago by Dow Jones

DJ Veeva Systems Is Maintained at Overweight by Barclays, from 12 hours ago by Dow Jones

DJ Veeva Systems Is Maintained at Outperform by RBC Capital, from 13 hours ago by Dow Jones

Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW, from 13 hours ago by Dow Jones

DEADLINE ALERT for IREN, AILE, and EW: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders, from 14 hours ago by Dow Jones

Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW, from 14 hours ago by Dow Jones

UBS Adjusts Price Target on Veeva Systems to $245 From $215, Maintains Neutral Rating, from 14 hours ago by MT Newswires